Tag: Cancer: Uterine
Taxane + Platinum Feasible for Adjuvant Tx in Endometrial Cancer
Tolerability, survival similar to that for doxorubicin + cisplatin for postoperative adjuvant chemotherapy
Fewer Complications After MIRS Introduced for Endometrial Cancer
Introduction of minimally invasive robotic surgery linked to reduced odds of severe complications
Since 1999, Uterine Cancer Incidence, Mortality Up
Incidence of uterine cancer higher among non-Hispanic black and white women; more deaths for blacks
Sentinel Lymph Node Mapping Most Cost-Effective for Uterine CA
Findings compared to routine, selective lymphadenectomy for low-risk endometrial cancer
Most Postmenopausal Bleeding Not Associated With Cancer
Most women with endometrial CA have bleeding, but risk of CA among those with bleeding just 9 percent
Long-Term Cardiovascular Risk for Endometrial Cancer Survivors
Elevated risk of various cardiovascular outcomes, including pulmonary heart disease, atrial fibrillation
New Drug Combo Ups Survival in HER2/neu Uterine Serous Cancer
Adding intravenous trastuzumab to carboplatin-paclitaxel increased progression-free survival
Genetic Assay of PAP Tests May Help Dx Endometrial, Ovarian CA
PapSEEK tests for gene mutation, aneuploidy; better detection with Tao brush intrauterine sampling
Levonorgestrel IUD Feasible for Low-Risk, Early Uterine Cancer
Majority of women responded well and returned to normal histology in six months
Endometrial Ablation Doesn’t Increase Cancer Risk
No increased risk of endometrial, breast cancer for women in Finland treated with endometrial ablation
